| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/28/2011 | CN101370586B Apparatus for determining the presence of a contaminant in a sample of water or other fluid |
| 09/28/2011 | CN101315345B Production method for Modified electrode for detecting grape-sugar concentration in non-enzyme condition |
| 09/28/2011 | CN101311726B Image detection method for detection disk |
| 09/28/2011 | CN101201359B ELISA reagent box for detecting metaphase factor concentration and method of use thereof |
| 09/28/2011 | CN101139574B LRP16 monoclonal antibody hybrid oncocyte strain and uses thereof |
| 09/28/2011 | CN101046435B Blood analyzing apparatus |
| 09/28/2011 | CN101000341B Sensor type on-line monitor of biochemical oxygen demand |
| 09/27/2011 | US8027824 Protein switches incorporating cytochrome C3 in monolayers and method for producing same |
| 09/27/2011 | US8027823 Methods and system for viewing genomic data |
| 09/27/2011 | US8027822 Interactive, internet supported health and fitness management system |
| 09/27/2011 | US8027821 Method for determining gene knockouts |
| 09/27/2011 | US8027791 Self-improving classification system |
| 09/27/2011 | US8026353 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases |
| 09/27/2011 | US8026351 Monocyte-derived nucleic acids and related compositions and methods |
| 09/27/2011 | US8026346 Tribonectins |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026221 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 09/27/2011 | US8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2011 | US8026108 Detection of biotargets using bioreceptor functionalized nanoparticles |
| 09/27/2011 | US8026107 Agglutination inhibition assay method and reagent |
| 09/27/2011 | US8026105 Quantification of lubricant reactivity using constant volume combustion device |
| 09/27/2011 | US8026103 Breath test for total organic carbon |
| 09/27/2011 | US8026102 Apparatus and method to characterize blood and red blood cells via erythrocyte membrane fragility quantification |
| 09/27/2011 | US8026101 Failure detection in automated clinical analyzers |
| 09/27/2011 | US8026099 Lipid profile as a biomarker for early detection of neurological disorders |
| 09/27/2011 | US8026094 Microarray synthesis instrument and method |
| 09/27/2011 | US8026080 Real time electronic cell sensing system and applications for cell-based assays |
| 09/27/2011 | US8026078 Method of quantifying glycosylated protein using redox reaction and quantification kit |
| 09/27/2011 | US8026077 Using presence of protein kinase C gamma (PKCg) complexes as diagnostic indicator which distinguish between hypoxic encephalopathies |
| 09/27/2011 | US8026076 IP-10 based immunological monitoring |
| 09/27/2011 | US8026075 Method for stabilizing coenzyme and composition thereof |
| 09/27/2011 | US8026074 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis |
| 09/27/2011 | US8026073 Screening G protein-coupled receptor antagonists for methods of treating Alzheimer's disease |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | US8026071 Systems and methods for detecting target analytes |
| 09/27/2011 | US8026070 Differential detection of multimeric and monomeric forms of multimer-forming polypeptides |
| 09/27/2011 | US8026069 Process for identification of compounds for modulating the activity of sodium/calcium exchange transporter |
| 09/27/2011 | US8026054 Antibodies against cells of fetal origin |
| 09/27/2011 | US8026049 Noninvasive measurement and identification of biomarkers in disease state |
| 09/27/2011 | US8025891 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | US8025850 Rapid diagnostic device, assay and multifunctional buffer |
| 09/27/2011 | US8025849 Oral fluid collection, transfer and transportation device and method |
| 09/27/2011 | US8025844 Hydrogen sensor and hydrogen gas detecting apparatus |
| 09/27/2011 | US8025843 Hydrogen sensor |
| 09/27/2011 | US8025788 Method for manufacturing an enzymatic reagent ink |
| 09/27/2011 | US8025779 Water quality analyzer |
| 09/27/2011 | US8024985 Systems and methods for evaluating material for pulling rolls |
| 09/27/2011 | DE202011102872U1 Elutionssäule mit austauschbaren Filterplatten und Schnellspannvorrichtungen Elution column with replaceable filter plates and quick-release devices |
| 09/27/2011 | CA2494022C Agent for detecting malondialdehyde, method of making the same, and test kit for use thereof |
| 09/27/2011 | CA2472233C Biomolecule and biomolecular information storage onto an integrated circuit |
| 09/27/2011 | CA2468849C Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 09/27/2011 | CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 09/27/2011 | CA2447276C Non-human animal model of oligodendrocyte developmental disorder |
| 09/27/2011 | CA2425112C Massive parallel method for decoding dna and rna |
| 09/27/2011 | CA2380919C System and method for manipulating magnetically responsive particles in fluid samples to collect dna or rna from a sample |
| 09/27/2011 | CA2356303C Structural detection process for monocrystalline superalloys |
| 09/27/2011 | CA2340720C Detection of contaminants using self-contained devices employing target material binding dyes |
| 09/27/2011 | CA2336218C Neurotrophic factors |
| 09/27/2011 | CA2283742C Fiber optic sensor with encoded microspheres |
| 09/27/2011 | CA2283058C Procedure for simultaneous determination of hiv antigens and hiv antibodies |
| 09/27/2011 | CA2279476C Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions |
| 09/27/2011 | CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies |
| 09/22/2011 | WO2011116401A2 Arsenical fluorescent agents and assays |
| 09/22/2011 | WO2011116380A2 Hybrid model for the classification of carcinoma subtypes |
| 09/22/2011 | WO2011116353A2 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | WO2011116311A1 Determining susceptibility to a sudden cardiac event |
| 09/22/2011 | WO2011116305A1 Method and apparatus for optically determining at least one hemoglobin related parameter of a whole blood sample |
| 09/22/2011 | WO2011116276A2 Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates |
| 09/22/2011 | WO2011116256A2 Multiphase microarrays and uses thereof |
| 09/22/2011 | WO2011116245A2 Methods of treating inflammation |
| 09/22/2011 | WO2011116214A1 Methods of identifying insect-trpa1 modulators |
| 09/22/2011 | WO2011116211A2 Salinity sensor for embedded environmental monitoring |
| 09/22/2011 | WO2011116209A2 Using phage epitopes to profile the immune response |
| 09/22/2011 | WO2011116181A1 Theranostic and diagnostic methods using sparc and hsp90 |
| 09/22/2011 | WO2011116151A2 Enzyme-logic biosensing |
| 09/22/2011 | WO2011116128A1 Methods for predicting cardiovascular events and monitoring treatment using pcsk9 |
| 09/22/2011 | WO2011116120A2 Method and apparatus for addressable flow cells in single molecule sequencing |
| 09/22/2011 | WO2011116111A1 Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease |
| 09/22/2011 | WO2011116028A1 Improved mass spectrometric assays for peptides |
| 09/22/2011 | WO2011116023A1 METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
| 09/22/2011 | WO2011116006A2 A rapid method to measure cyanide in biological samples |
| 09/22/2011 | WO2011115977A2 Salivary bioassay for early detection of bone loss |
| 09/22/2011 | WO2011115937A1 Methods of determining susceptibility of tumors to tyrosine kinase inhibitors |
| 09/22/2011 | WO2011115819A2 Small molecule inhibitors of muc1 and methods of identifying the same |
| 09/22/2011 | WO2011115809A2 High energy radiation insensitive analyte sensors |
| 09/22/2011 | WO2011115783A1 Methods for assessing the risk of cardiovascular disease |
| 09/22/2011 | WO2011115580A1 A process for making an array |
| 09/22/2011 | WO2011115470A1 Gelatin detection and differentiation methods thereof |
| 09/22/2011 | WO2011115465A2 Method and kit for detection of pathogen of female genital organs using multiplex liquid array system |
| 09/22/2011 | WO2011115445A2 Biochip |
| 09/22/2011 | WO2011115435A2 Thiol derivative of biotin, and analysis method of substrate specificity of serine/threonine kinase using same |
| 09/22/2011 | WO2011115271A1 Tumor angiogenesis inhibitor |
| 09/22/2011 | WO2011115231A1 Osteopontin specific monoclonal antibody |
| 09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 09/22/2011 | WO2011115222A1 Florigen-activating complex |
| 09/22/2011 | WO2011115189A1 Cell activity analysis device, cell activity analysis method and cell analysis method |
| 09/22/2011 | WO2011115028A1 Information acquisition device, measurement system, and information acquisition method |
| 09/22/2011 | WO2011114732A1 Circadian rhythm measurement method |
| 09/22/2011 | WO2011114538A1 Optical Fuel Sensor |